Company intelligence / Profile preview

BlueBridge Technologies

Dublin, Ireland

Ownership: Private
Development stage: Other

Overview

BlueBridge Technologies develops and operates regulated software and connected-device ecosystems, digital diagnostics, and end-to-end patient-to-cloud platforms used commercially to manage chronic diseases and digitize clinical trials and patient outcomes for med‑tech and pharmaceutical customers[1][2].

Therapeutic areas: EndocrinologyCardiovascularNeurologyPulmonologyOncology
Modalities: DeviceNon-pharmacological therapySoftware as a medical deviceDigital therapeutics
Industry: Digital Health Medical Devices

Partnerships

Actuate Technologies (collaboration on Respr handheld device using real-time satellite data for Covid-19 monitoring)[1]European Space Agency (ESA) contracts via Covid-19 response and space-based health solutions)[1]

Beyond the preview

Go deeper on BlueBridge Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BlueBridge Technologies.

Explore the full profile